1175769

U.S. Continental Marketing, Inc. — FEI 3005519645

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 21, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Corona, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
117721 CFR 211.63Equipment Design, Size and Location
121521 CFR 211.67(b)Written procedures not established/followed
154021 CFR 211.125(a)Strict control not exercised over labeling issued